Abstract
Astrocytes, the largest cell population in the human brain, are powerful inflammatory effectors. Several studies have examined the interaction of activated astrocytes with neurons, but little is known yet about human neurotoxicity under such situations and about strategies of neuronal rescue. To address this question, immortalized murine astrocytes (IMA) were combined with human LUHMES neurons and stimulated with an inflammatory (TNF, IL-1) cytokine mix (CM). Neurotoxicity was studied both in co-cultures and in monocultures after transfer of conditioned medium from activated IMA. Interventions with >20 drugs were used to profile the model system. Control IMA supported neurons and protected them from neurotoxicants. Inflammatory activation reduced this protection, and prolonged exposure of co-cultures to CM triggered neurotoxicity. Neither the added cytokines nor the release of NO from astrocytes were involved in this neurodegeneration. The neurotoxicity-mediating effect of IMA was faithfully reproduced by human astrocytes. Moreover, glia-dependent toxicity was also observed, when IMA cultures were stimulated with CM, and the culture medium was transferred to neurons. Such neurotoxicity was prevented when astrocytes were treated by p38 kinase inhibitors or dexamethasone, whereas such compounds had no effect when added to neurons. Conversely, treatment of neurons with five different drugs, including resveratrol and CEP1347, prevented toxicity of astrocyte supernatants. Thus, the sequential IMA-LUHMES neuroinflammation model is suitable for separate profiling of both glial-directed and directly neuroprotective strategies. Moreover, direct evaluation in co-cultures of the same cells allows for testing of therapeutic effectiveness in more complex settings, in which astrocytes affect pharmacological properties of neurons.
Similar content being viewed by others
Abbreviations
- PD:
-
Parkinson’s disease
- DA:
-
Dopaminergic
- MPP+ :
-
1-Methyl-4-phenyl-pyridinium
- PARP:
-
Poly-(ADP-ribose)-polymerase
- PLO:
-
Poly-l-ornithine
- GDNF:
-
Glial-derived neurotrophic factor
- IMA:
-
Immortalized mouse astrocytes
- LDH:
-
Lactate dehydrogenase
- DTNB:
-
5,5′-Dithiobis(2-nitrobenzoic acid)
- GSH:
-
Glutathione
- GSSG:
-
l-Glutathione oxidized
- DHQ:
-
1,5-Isoquinolinediol
- CEP1347:
-
(3,9-Bis[(ethylthio)methyl]-K-252a)
- ROCK:
-
Rho kinase
- DM:
-
Differentiation medium
- DAT:
-
Dopamine transporter
- LUHMES:
-
Lund human mesencephalic cells
- TNF-α:
-
Tumor necrosis factor alpha
- IL-1β:
-
Interleukin-1 beta
- IFN-γ:
-
Interferon gamma
- CM:
-
Cytokine mix
- CCM:
-
Complete cytokine mix
- L-NNA:
-
Nω-nitro-l-arginine
- CNS:
-
Central nerve system
- VMAT2:
-
Vesicular monoamine transporter
- TH:
-
Tyrosine hydroxylase
- NHA:
-
Normal human astrocytes
- NF-kB:
-
Nuclear factor kappa-light-chain-enhancer of activated B cells
- IkB:
-
NF-kappa-B inhibitor beta
- COX2:
-
Cyclooxygenase-2
- NOS:
-
Nitric oxide synthase
- cAMP:
-
Cyclic adenosine monophosphate
- NEP:
-
Neuroepithelial cells
- mAGES:
-
Mouse astrocytes generated from embryonic stem cells
- SNpc:
-
Substantia nigra pars compacta
- LPS:
-
Lipopolysaccharides
- NSE:
-
Neuron-specific enolase
References
Allen NJ, Barres BA (2009) Glia—more than just brain glue. Nature 457:675–677
Avendano BC, Montero TD, Chavez CE, von Bernhardi R, Orellana JA (2015) Prenatal exposure to inflammatory conditions increases Cx43 and Panx1 unopposed channel opening and activation of astrocytes in the offspring effect on neuronal survival. Glia 63(11):2058–2072
Bal-Price A, Brown GC (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci Off J Soc Neurosci 21(17):6480–6491
Bal-Price A, Moneer Z, Brown GC (2002) Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 40(3):312–323
Bi F, Huang C, Tong J, Qiu G, Huang B, Wu Q et al (2013) Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci USA 110:4069–4074
Biber K, Owens T, Boddeke E (2014) What is microglia neurotoxicity (not)? Glia 62:841–854
Biesmans S, Acton PD, Cotto C, Langlois X, Ver Donck L, Bouwknecht JA et al (2015) Effect of stress and peripheral immune activation on astrocyte activation in transgenic bioluminescent Gfap-luc mice. Glia 63:1126–1137
Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69
Bodea LG, Wang Y, Linnartz-Gerlach B, Kopatz J, Sinkkonen L, Musgrove R et al (2014) Neurodegeneration by activation of the microglial complement-phagosome pathway. J Neurosci 34:8546–8556
Brown GC, Neher JJ (2010) Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 41:242–247
Buffo A, Rolando C, Ceruti S (2010) Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 79:77–89
Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS et al (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28:264–278
Carbone M, Duty S, Rattray M (2012) Riluzole neuroprotection in a Parkinson’s disease model involves suppression of reactive astrocytosis but not GLT-1 regulation. BMC Neurosci 13:38
Castillo J, Dávalos A, Alvarez-Sabín J, Pumar JM, Leira R et al (2002) Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 58:624–629
Chen Y, Vartiainen NE, Ying W, Chan PH, Koistinaho J, Swanson RA (2001) Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J Neurochem 77:1601–1610
Cipriani S, Desjardins CA, Burdett TC, Xu Y, Xu K, Schwarzschild MA (2012) Protection of dopaminergic cells by urate requires its accumulation in astrocytes. J Neurochem 123:172–181
Dodla MC, Mumaw J, Stice SL (2010) Role of astrocytes, soluble factors, cells adhesion molecules and neurotrophins in functional synapse formation: implications for human embryonic stem cell derived neurons. Curr Stem Cell Res Ther 5:251–260
Efremova L, Schildknecht S, Adam M, Pape R, Gutbier S, Hanf B et al (2015) Prevention of human dopaminergic neurodegeneration in an astrocytes co-culture system allowing endogenous drug metabolism. Br J Pharmacol 172:4119–4132
Falsig J, Latta M, Leist M (2004a) Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. J Neurochem 88:181–193
Falsig J, Porzgen P, Lotharius J, Leist M (2004b) Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347. J Immunol 173:2762–2770
Falsig J, Porzgen P, Lund S, Schrattenholz A, Leist M (2006) The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J Neurochem 96:893–907
Falsig J, van Beek J, Hermann C, Leist M (2008) Molecular basis for detection of invading pathogens in the brain. J Neurosci Res 86:1434–1447
Forno LS, DeLanney LE, Irwin I, Di Monte D, Langston JW (1992) Astrocytes and Parkinson’s disease. Prog Brain Res 94:429–436
Gallardo G, Barowski J, Ravits J, Siddique T, Lingrel JB, Robertson J et al (2014) An alpha2-Na/K ATPase/alpha-adducin complex in astrocytes triggers non-cell autonomous neurodegeneration. Nat Neurosci 17:1710–1719
Gandelman M, Peluffo H, Beckman JS, Cassina P, Barbeito L (2010) Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis. J Neuroinflammation 7:33
Gantner F, Leist M, Kusters S, Vogt K, Volk HD, Tiegs G (1996) T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp Cell Res 229:137–146
Gao X, Chen H, Schwarzschild MA, Ascherio A (2011) Use of ibuprofen and risk of Parkinson disease. Neurology 76:863–869
Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W (2011) Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis 2:e167
Gegg ME, Clark JB (1036) Heales, SJ (2005) Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity. Brain Res 1–2:1–6
Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L et al (2015) Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518:547–551
Guizzetti M, Moore NH, Giordano G, Costa LG (2008) Modulation of neuritogenesis by astrocyte muscarinic receptors. J Biol Chem 283:31884–31897
Gupta K, Patani R, Baxter P, Serio A, Story D, Tsujita T et al (2012) Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ 19:779–787
Hansson O, Castilho RF, Kaminski Schierle GS, Karlsson J, Nicotera P, Leist M et al (2000) Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons. Exp Neurol 164:102–111
Hashioka S, McGeer EG, Miyaoka T, Wake R, Horiguchi J, McGeer PL (2015) Interferon-gamma-induced neurotoxicity of human astrocytes. CNS Neurol Disord: Drug Targets 14(2):251–256
Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14(7):463–477
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14(4):388–405
Henn A, Kirner S, Leist M (2011) TLR2 hypersensitivity of astrocytes as functional consequence of previous inflammatory episodes. J Immunol 186:3237–3247
Hunter RL, Cheng B, Choi DY, Liu M, Liu S, Cass WA et al (2009) Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice. J Neurosci Res 87:1913–1921
In’T Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T et al (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med 345:1515–1521
Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Czlonkowski A, Czlonkowska A (1998) Microglial and astrocytic involvement in a murine model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology 39:167–180
Krug AK, Gutbier S, Zhao L, Poltl D, Kullmann C, Ivanova V et al (2014) Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+). Cell Death Dis 5:e1222
Kuegler PB, Baumann BA, Zimmer B, Keller S, Marx A, Kadereit S et al (2012) GFAP-independent inflammatory competence and trophic functions of astrocytes generated from murine embryonic stem cells. Glia 60:218–228
Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybylkowski A, Czlonkowski A et al (2004) Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson’s disease. Int Immunopharmacol 4:1307–1318
Lee M, Cho T, Jantaratnotai N, Wang YT, McGeer E, McGeer PL (2010) Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J 24(7):2533–2545
Lee M, McGeer E, Kodela R, Kashfi K, McGeer PL (2013a) NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders. Glia 61(10):1724–1734
Lee M, McGeer E, McGeer PL (2013b) Neurotoxins released from interferon-gamma-stimulated human astrocytes. Neuroscience 229:164–175
Lindholm P, Voutilainen MH, Lauren J, Peranen J, Leppanen VM, Andressoo JO et al (2007) Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature 448:73–77
Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK et al (2011) A role for glia in the progression of Rett’s syndrome. Nature 475:497–500
Lukovic D, Stojkovic M, Moreno-Manzano V, Jendelova P, Sykova E, Bhattacharya SS et al (2015) Concise review: reactive astrocytes and stem cells in spinal cord injury: good guys or bad guys? Stem Cells 33:1036–1041
Ma D, Jin S, Li E, Doi Y, Parajuli B, Noda M et al (2013) The neurotoxic effect of astrocytes activated with toll-like receptor ligands. J Neuroimmunol 254:10–18
Mander P, Borutaite V, Moncada S, Brown GC (2005) Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. J Neurosci Res 79(1–2):208–215
Maragakis NJ, Rothstein JD (2006) Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2:679–689
Mattson MP, Barger SW, Furukawa K, Bruce AJ, Wyss-Coray T, Mark RJ et al (1997) Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer’s disease. Brain Res Brain Res Rev 23:47–61
Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI et al (2014) Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med 20:1147–1156
Medeiros R, LaFerla FM (2013) Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol 239:133–138
Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10(5):615–622
Orre M, Kamphuis W, Osborn LM, Jansen AH, Kooijman L, Bossers K et al (2014) Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction. Neurobiol Aging 35:2746–2760
Pekny M, Wilhelmsson U, Bogestal YR, Pekna M (2007) The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 82:95–111
Pizzurro DM, Dao K, Costa LG (2014) Astrocytes protect against diazinon- and diazoxon-induced inhibition of neurite outgrowth by regulating neuronal glutathione. Toxicology 318:59–68
Puschmann TB, Zanden C, De Pablo Y, Kirchhoff F, Pekna M, Liu J et al (2013) Bioactive 3D cell culture system minimizes cellular stress and maintains the in vivo-like morphological complexity of astroglial cells. Glia 61:432–440
Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE et al (2011) Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson’s disease: evidence from observational studies. Cochrane Database Syst Rev. doi:10.1002/14651858.CD008454
Robel S, Berninger B, Gotz M (2011) The stem cell potential of glia: lessons from reactive gliosis. Nat Rev Neurosci 12:88–104
Ruitenberg A, Kalmijn S, de Ridder MA, Redekop WK, van Harskamp F, Hofman A et al (2001) Prognosis of Alzheimer’s disease: the Rotterdam Study. Neuroepidemiology 20:188–195
Sandstrom von Tobel J, Zoia D, Althaus J, Antinori P, Mermoud J, Pak HS et al (2014) Immediate and delayed effects of subchronic Paraquat exposure during an early differentiation stage in 3D-rat brain cell cultures. Toxicol Lett 230:188–197
Schildknecht S, Kirner S, Henn A, Gasparic K, Pape R, Efremova L et al (2012) Characterization of mouse cell line IMA 2.1 as a potential model system to study astrocyte functions. Altex Altern Anim Exp 29:261–274
Scholz D, Poltl D, Genewsky A, Weng M, Waldmann T, Schildknecht S et al (2011) Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J Neurochem 119:957–971
Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H et al (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 23:3394–3406
Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5:146–156
Simon BM, Malisan F, Testi R, Nicotera P, Leist M (2002) Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ 9:758–767
Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35
Valenza M, Marullo M, Di Paolo E, Cesana E, Zuccato C, Biella G et al (2015) Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington’s disease. Cell Death Differ 22:690–702
Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6:626–640
Walker DG, Kim SU, McGeer PL (1998) Expression of complement C4 and C9 genes by human astrocytes. Brain Res 809(1):31–38
Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A et al (2012) Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 287:21384–21395
Ward RJ, Colivicchi MA, Allen R, Schol F, Lallemand F, de Witte P, Ballini C et al (2009) Neuro-inflammation induced in the hippocampus of ‘binge drinking’ rats may be mediated by elevated extracellular glutamate content. J Neurochem 111:1119–1128
Williams EC, Zhong X, Mohamed A, Li R, Liu Y, Dong Q et al (2014) Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet 23:2968–2980
Acknowledgments
This work was supported by the Doerenkamp-Zbinden Foundation, the Land BW, the DFG (RTG1331; KoRS-CB), the BMBF, and University of Konstanz funds.
Author’s contribution
Liudmila Efremova and Petra Chovancova performed most experiments, analyzed data, and wrote the manuscript; Stefan Schildknecht, Martina Adam, and Simon Gutbier performed experiments and proofread the manuscript; Marcel Leist designed experiments and wrote the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Liudmila Efremova and Petra Chovancova have contributed equally to this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Efremova, L., Chovancova, P., Adam, M. et al. Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation. Arch Toxicol 91, 231–246 (2017). https://doi.org/10.1007/s00204-016-1702-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-016-1702-2